$DLO

dLocal to Report Second Quarter 2026 Financial Results

dLocal Limited (NASDAQ: DLO) said it will release second-quarter 2026 financial results for the quarter ended June 30, 2026 on Aug. 13, 2026 after market close. The company will hold a conference call and video webcast that day at 5:00 p.m. ET, with an archived webcast available for one year.

Original reporting
Published Jun 5, 2026, 9:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 5, 2026, 10:16 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
dLocal to Report Second Quarter 2026 Financial Results — source image
Decision brief

The 30-second read

$DLONeutralMed
01

Why it matters

The announcement primarily informs traders of the next earnings catalyst window; without any Q2 figures or guidance, it does not change fundamental expectations by itself.

02

Market read

Confirms the earnings calendar for DLO, which can influence positioning, options implied volatility, and near-term trading plans ahead of the print.

03

What to watch

Traders may still need to monitor pre-announcement leaks, analyst estimate changes, and any concurrent macro/FX moves that can affect cross-border payment economics into Aug 13.

Relevance 7/10Novelty 5/10Timing: Earnings release scheduled for Aug 13 after market close; conference call at 5:00 p.m. ET.

Background

dLocal is a cross-border payments platform serving merchants and payouts across emerging markets; it scheduled its Q2 2026 results release and webcast.

Company-level read

Ticker impact

$DLONeutralMedium confidence
Context

dLocal announced it will report Q2 2026 results on Aug 13, setting a concrete earnings-catalyst date for DLO shares.

Expected impact

Likely modest pre-earnings drift/volatility; direction depends on Q2 results and guidance, which are not provided here.

Evidence & confidence

This is an event-date disclosure (earnings calendar) without new financial datapoints, so impact is primarily timing/volatility rather than fundamentals.

Market effects

Adds another scheduled catalyst for cross-border payments/EM fintech names, but no sector-wide read-across is provided.

No direct regional operational update beyond the company’s general EM footprint.

Limited—this is company-specific scheduling rather than a global payments development.

Counterpoint

Because the release date is already foreseeable via typical reporting cadence, the market may discount this quickly unless paired with new guidance elsewhere.

Key entities

  • dLocal Limited

    Announced Q2 2026 financial results timing and conference call details.

Related articles

$MURMedAI 8/10

Murphy Oil Sees Sharp Profit Increase

Murphy Oil Corp reported Q2 2026 adjusted net income of $225.8 million, nearly six times Q2 2025, as higher oil prices offset lower production and weaker gas. Adjusted EPS was $1.55 vs $1.51 consensus. Revenue rose to $926.3 million. Murphy kept its $0.35 dividend and raised 2026 capex midpoint to $1.55 billion.

$GSBDMed

Goldman Sachs BDC Q2 Earnings Call Highlights

Goldman Sachs BDC (NYSE:GSBD) reported no incentive fee in Q2, citing its three-year total-return lookback provision. NAV was $12.06/share at June 30 vs $12.17 in Q1. The board declared a Q3 base dividend of $0.32/share plus $0.03 supplemental. Investments were $3.2B fair value, non-accrual 2.9%, and net debt-to-equity 1.35x.

$HBBMed

Hamilton Beach Brands Q2 Earnings Call Highlights

Hamilton Beach Brands (HBB) reported Q2 gross margin of 26.1% excluding tariff-related benefits, and said it expects 2026 revenue growth in the mid-single-digit range. Management forecast full-year gross margin to improve modestly and operating profit to decline by a high-single-digit percentage. Operating cash flow is expected at $35M to $45M. HBB ended with net cash of $51.5M.

$GXOMed

GXO Logistics Q2 Earnings Call Highlights

GXO Logistics reported Q2 results and said it secured over $1 billion in expected incremental new-business revenue for 2026 and about $353 million for 2027. Management cited a $2.7 billion sales pipeline after quarter end. Operating cash flow was $76 million, free cash flow positive $12 million, cash $769 million, and net leverage 2.6x. GXO plans to target EBIT margins above 6% and deploy AI across ~50 sites in 2026.

$GRNDMed

Grindr Q2 Earnings Call Highlights

Grindr (NYSE:GRND) said free users remain central to its strategy, while AI tools are boosting engineering productivity. Management estimated engineering output rose about 2.5x from July 2025 to April 2026 with similar headcount, supporting a 39% to 42% adjusted EBITDA margin outlook. EDGE AI premium tier rollout is planned for later in fall; operating expenses ex cost of revenue were $71M vs $53M.

$HAEMedAI 8/10

Haemonetics Q1 Earnings Call Highlights

Haemonetics (NYSE:HAE) reported Q1 interventional technologies returning to 3% organic growth, with vascular closure led by VASCADE MVP and MVP XL momentum in the U.S. Apheresis revenue rose 6% organically to $191M and plasma revenue grew 8% organically as Persona PLUS rollout accelerates. Haemonetics raised FY2027 revenue guidance to 5% to 8% reported and 4% to 7% organic.